Ads
related to: moderna vaccine
Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 9 hours agoFurther, Moderna confirmed it's in discussions with the U.S. government to move forward with its...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 2 hours agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
Moderna shares rise as Argus lifts price target to $150 By Investing.com
Investing.com· 7 hours agoThe firm's decision follows the U.S. Food and Drug Administration's (FDA) approval of Moderna's...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 3 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Kansas sues Pfizer over ‘misleading statements’ about COVID vaccine
The Hill via Yahoo News· 3 days agoThe state of Kansas filed a lawsuit Monday against pharmaceutical company Pfizer, alleging the...
Analyst Report: Moderna Inc
Argus Research via Yahoo Finance· 8 hours agoModerna Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious and cardiovascular ...
Moderna Just Gave Investors Another Reason to Buy the Stock | The Motley Fool
The Motley Fool· 5 days agoModerna (MRNA -3.58%) is best known for its work in the coronavirus vaccine market. Let's look...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Market Whales and Their Recent Bets on MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 9 hours agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with ...
Moderna (NASDAQ:MRNA) Stock Price Down 3.9% After Insider Selling
ETF DAILY NEWS· 16 hours agoModerna, Inc. (NASDAQ:MRNA – Get Free Report)’s share price fell 3.9% during trading on Tuesday following insider selling activity. 1,055,980 shares changed hands during mid-day ...